.Blenrep (also called belantamab mafodotin) has been approved in the UK. It is a new* treatment for MM.
*It had previously been approved, but was then withdrawn. This re-approval follows further clinical trials, specifically the DREAMM7 and DREAMM8 trials. These indicate that Blenrep is generally more effective than the existing treatments for patients who have relapsed.
See: https://pharmaphorum.com/news/gsk-cements-blenrep-comeback-mhra-approval
Regards
Rabbit
